" class="no-js "lang="en-US"> James Leiper - Medtech Alert
Monday, May 20, 2024
James Leiper

James Leiper

About James Leiper

James Leiper is Professor of Molecular Medicine in the Institute for Cardiovascular and Medical Sciences at the University of Glasgow. Originally trained in molecular biology at the MRC Clinical Research Centre, James became interested in cardiovascular physiology whilst working at the Centre for Clinical Pharmacology at UCL and continued this work after taking up a position as Programme Leader at the MRC Laboratory for Medical Sciences.

He has undertaken internationally leading research in the field of vascular physiology and his work had led to the creation of a new biotechnology company focused on developing new medicines for the treatment of sepsis.

Professor Leiper will be based at the BHF for most of the week but will continue his research at the University of Glasgow.

Related Story

Obesity Linked to Damaging Changes in Failing Hearts

June 9 2022

Obesity is linked to changes in the structure and pumping action of the heart before […]

Genes Responsible for High Blood Pressure Discovered in the Human Kidney

May 7 2021

Research that the British Heart Foundation part-funded has led to the discovery of 179 kidney […]

Glowing Probe Could Diagnose Cardiovascular Disease Earlier

May 6 2021

Researchers have created a probe that glows when it detects an enzyme associated with issues […]

BHF Secure EU Approval for CaRi-Heart®

March 29 2021

The first-of-its-kind technology, CaRi-Heart®, was developed by spinout company Caristo Diagnostics and has the power […]